ABBV vs LLY
AbbVie Inc · Eli Lilly and Company
Relative return (rebased to 100)
Key stats
| Metric | ABBV | LLY |
|---|---|---|
| Price | $285.64 | $1,273.46 |
| Market Cap | $504.76B | $1.20T |
| P/E | 119.44 | 58.08 |
| P/B | — | 35.38 |
| P/S | 8.25 | 18.39 |
| ROE | — | 60.9% |
| Net Margin | 6.9% | 31.7% |
| Gross Margin | — | — |
| Revenue Growth | 8.6% | 44.7% |
| Dividend Yield | 2.33% | 0.49% |
| EPS | $2.39 | $21.93 |
Metrics from owned fundamentals, updated daily. Highlighted values are the more favorable of the two.